Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

0.9968
Delayed Data
As of 3:58pm ET
 -0.0232 / -2.27%
Today’s Change
0.80
Today|||52-Week Range
4.90
-33.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-40.5M-28.0M-39.6M-36.7M
 
 
 
 
 
Depreciation4.4M4.3M3.3M3.4M
 
 
 
 
 
Total Other Cash Flow7.2M3.1M40.0M-5.3M
 
 
 
 
 
Funds From Operations-28.9M-20.5M3.7M-38.7M
 
 
 
 
 
Funds From/For Other Operating Expenses5.5M-2.3M4.3M2.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-34.4M-18.2M-612.0K-41.5M
 
 
 
 
 
 
InvestingIncrease In Investments-28.5M0.00-19.2M-42.0M
 
 
 
 
Decrease In Investments54.0M2.0M10.7M30.8M
 
 
 
 
 
Capital Expenditures-496.0K-452.0K-1.8M-2.4M
 
 
 
 
 
Fixed Asset Disposal0.00425.0K16.0K0.00
 
 
 
Net Cash Flow Investing25.1M2.0M-10.3M-13.5M
 
 
 
 
 
 
FinancingShort Term Borrowings---6.1M0.000.00
 
 
Long Term Borrowings--0.0015.0M50.8M
 
 
 
Long Term Debt Reduction-5.6M0.00-5.8M-781.0K
 
 
 
 
Net Proceeds Stock Sale16.1M35.2M6.6M5.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.005.1M0.00
 
 
Other Uses - Financing0.0010.1M10.3M3.0M
 
 
 
 
Net Cash Flow - Financing10.6M19.1M10.5M52.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash1.2M2.8M-409.0K-2.1M